Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
This study has been completed.
Rhythm Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Motus Therapeutics, Inc. ( Rhythm Pharmaceuticals, Inc. )
First received: April 2, 2012
Last updated: November 6, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||September 2013|
|Primary Completion Date:||August 2013 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Received:||November 6, 2014|